Boule Diagnostics wins tenders in Egypt

Boule Diagnostics AB has won two major public tenders in Egypt for around 200 hematology systems in total. Successive deliveries of the instruments will start in December 2016. The final shipment is expected to be made in the first half of 2017. The procuring authorities are the Ministry of Defence and Ministry of Health.

“Egypt is a large and very interesting market for Boule and we feel we can continue to grow and take market shares there. We are naturally delighted that our run of public tender successes is continuing as it confirms that demand for our high quality products is increasing,” said Ernst Westman, CEO and President, Boule Diagnostics.

For more information, please contact:  Ernst Westman, CEO and President, Boule Diagnostics AB, tel +46 708-60 88 63

About Boule Diagnostics AB

Boule Diagnostics AB is a fast-growing diagnostics company, developing and manufacturing systems and consumables for hematology diagnostics for the public healthcare providers worldwide. The company is primarily focused on small and medium-sized hospitals, clinics and laboratories in outpatient care as well as other diagnostics companies in both human and veterinary hematology. The group is comprised of operating subsidiaries in Sweden, the US and China. The Boule Diagnostics share is traded on NASDAQ Nordic since 2011.

This information is information that Boule Diagnostics AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET December 9 2016.


  • Subscribe to our news